SMR TT Hybrid Glenoid
LimaCorporate
SMR TT Hybrid Glenoid
The SMR TT Hybrid Glenoid is the first convertible 3D Printed* Hybrid Glenoid. The central peg is made in LimaCorporate’s patent technology.
*Trabecular Titanium.
BENEFITS
- Soft Tissue management – The wide range of sizes, mismatch options and thicknesses make SMR TT Hybrid Glenoid appropriate for soft tissue balancing.
- Convertible glenoid – SMR TT Hybrid Glenoid is invertible to reverse without the central peg removal.
- Reliable fixation – The 3D printed Trabecular Titanium central peg enhances primary and biological fixation. Poly peripheral pegs are also cemented.
As part of the SMR System, SMR TT Hybrid Glenoid has been designed to provide solutions for glenoid replacement. It allows soft tissue management, thanks to its wide range of sizes. The SMR TT Hybrid Glenoid features a polyethylene baseplate connected to a central Trabecular Titanium peg. Using dedicated instruments, the pre-assembled polyethylene baseplate can be disconnected, leaving the metal peg in place. A dedicated reverse baseplate can be connected to the central peg. The use of Trabecular Titanium for the central peg improves stability and tissue ingrowth. The material, the structure, the mechanical properties, and the enhanced initial fixation are the premises for an initial primary fixation followed by the biologic integration of the implants [1-5].
[1] A. M. Malhas, J. Granville-Chapman, P. M. Robinson, S. Brookes-Fazakerley, M. Walton, P. Monga, S. Bale, I. Trail Reconstruction of the glenoid using autologous bone-graft and the SMR Axioma TT metal-backed prosthesis. Bone Joint J 2018;100-B:1609–17.
[2] * E. Marin, L. Fedrizzi, M. Regis, M. Pressacco, L. Zagra, S. Fusi. Stability enhancement of prosthetic implants: friction analysis of Trabecular
TitaniumTM. Hip International, 22(4): 427-428, 2012.
[3] * V. Sollazzo, A. Palmieri, L. Massari, F. Carinci. Genetic effects of Trabecular TitaniumTM on cells MG-63 cell line: an in vitro study. J Orthpaed
Traumatol., 13(1): 107, 2012.
[4] * Benazzo F, Botta L, Scaffino MF, Caliogna L, Marullo M, Fusi S, Gastaldi G. Trabecular Titanium can induce in vitro osteogenic differentiation of
human adipose derived stem cells without osteogenic factors. J Biomed Mater Res Part A. 2014:102A:2061–71.
[5] * Devine D, Arens D, Burelli S, Bloch HR, Boure L. In vivo evaluation of the osteointegration of new highly porous Trabecular Titanium™. J Bone
Joint Surg Br. 2012;94-B(Suppl XXXVII):201.
*Results from clinical studies.
Enquire
For further information, questions regarding this product, or to discuss alternative solutions, please get in touch with your local Sales Specialist or our Head Office using the form or the contact details at the bottom of the page.
Stay in touch
NEWSLETTER
Sign up to receive email updates on new product announcements, insights on surgical techniques from surgeons, specialists, and sales representatives and industry trends, such as changes in regulations and new research findings.
